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Abstract. 
Giant cell tumor (GCT) is a benign but locally aggressive skeletal neoplasm of young 
adults. GCT located in the spine is relatively rare and may need a combination of surgical and 
adjunctive therapies. Here we present a patient who had intermittent thoracic back pain for two 
weeks and experienced an acute episode of decreased muscle power of both lower limbs. 
Magnetic resonance (MR) imaging examinations of the thoracic spine revealed that the patient 
had severe spinal canal compression caused by pathological fracture due to a tumor within the 
seventh thoracic vertebra. She underwent an emergent surgical intervention for total removal of 
the tumor and spinal reconstruction with autologous rib grafts and instruments. Postoperatively, 
the patient made an uneventful recovery of muscle power of bilateral lower limbs. She subse-
quently received adjuvant radiotherapy. In a follow-up period of 36 months, the patient had no 
clinical or radiological evidence of tumor recurrence. Even though spinal location for GCT is a 
rare event, it should be included in the differential diagnosis in patients with osteolytic lesions 
or pathological fractures of the vertebra, especially in young female patients sustaining no 
trauma who had a clinical history of persistent low back pain. 
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中文摘要 
  骨巨細胞瘤對年輕人來說是一種良性但具局部侵犯性的腫瘤，而發生在脊椎的骨巨
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 細胞瘤相對來說是少見的，在治療上必須合併手術以及後續的放射線治療。在此我們提
出一個病例報告，病人經歷兩個禮拜的間歇下背痛且惡化成為急性雙下肢無力，胸椎核
磁共振檢查中發現胸椎第七節的腫瘤造成病理性骨折以及嚴重的脊髓壓迫，在施行緊急
的腫瘤移除以及前固定手術後，下肢的肌力恢復到正常。病人後續接受脊椎的放射線治
療，追蹤到目前並無復發的情形。儘管脊椎骨巨細胞瘤相當少見，我們仍然強調在診斷
脊椎的病理性骨折以及蝕骨性病灶時，必須將其列為鑑別診斷之一，尤其是在沒有外傷
病史卻有長期下背痛的年輕女性身上。 
 
關鍵字: 急性下肢無力、病理性骨折、脊椎骨巨細胞瘤 
INTRODUCTION 
Giant cell tumor (GCT) is a solitary neoplasm 
mostly involving the distal femur or proximal tibia. 
Spinal localization for GCT is a relatively rare event, 
and predominantly involves the vertebral body of the 
lumbosacral spine. It is estimated that the prevalence 
of spinal involvement in GCTs is less than 3%. In par-
ticular, the involvement of GCT in the thoracic spine 
is extremely rare [1]. We, herein, report a patient who 
presented with acute paraparesis due to pathological 
fractures of the seventh thoracic (T7) vertebra caused 
by a GCT. Following combined surgical and irradia-
tion therapies, this patient made a favorable neuro-
logic recovery. Demographic data, characteristic im-
aging findings, treatment and outcome of the patient 
are discussed. 
 
CASE REPORT 
A 27-year-old female patient who had no history 
of systemic disease suffered from progressive intense 
posterior thoracic pain located in the midline around 
the 7th and 8th thoracic vertebrae for two weeks, and 
the pain was reported to radiate to the anterior costal 
margin. On the day of admission, she experienced an 
acute onset of bilateral lower limbs numbness and 
weakness accompanied with circumferential chest and 
back pain. She was also found to have severe weak-
ness (Motor Grade=2/5) of both lower limbs with 
sparing of the urinary and bowel sphincter function. 
Cranial nerve functions and other neurologic exami-
nations were unremarkable. The MRI images of the 
thoracic spine showed a tumor-induced pathological 
fracture of the T7 vertebra with severe compression of 
the spinal cord (Figure 1). The patient was diagnosed 
to have acute spinal cord compression caused by a 
metastatic lesion of the T7 vertebra. She subsequently 
underwent an emergent thoracotomy and T7 corpec-
tomy for total excision of the tumor and, then, spinal 
reconstruction with autologous rib grafts (part of left 
7th and 8th ribs) and instruments with a vertebral 
screwing and rod system (AO internal spine fixation 
system, Spine-tech, Orion). Pathological examinations 
showed that the lesion was a GCT of the T7 vertebra 
which revealed diffuse infiltration by numerous of 
mononuclear cells with round to oval nuclei and oste-
oclast-like multinucleated giant cells (Figure 2). 
Postoperatively, the patient made an uneventful re-
covery. Her muscle power of both lower limbs gradu-
ally recovered to normal levels (muscle power scale= 
5/5, bilaterally) within 2 weeks after the operation. 
The patient was examined with positron emission to-
mography (PET) examinations which revealed that the 
patient did not have other detectable lesions. The pa-
tient then received focal external beam radiotherapy 
up to 50 Gy in 25 fractions. The patient tolerated the 
treatment well. She remained progression-free and did 
not have notable clinical or MRI evidence of recur- 
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Figure 1. The T2-weighted MR imaging demonstrated (A) pathological fracture caused by a low intensity lesion 
within the 7th thoracic vertebra. In the axial sections (B), the tumor was noted to have bilateral exten-
sion to posterior spinal elements that resulted in severe spinal cord compression. After contrast enhanc-
ing(C,D), the tumor showed heterogeneous enhancement, showing possibility of myeloma, lymphoma, 
Langerhans cell histiocytosis in differential diagnosis 
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Figure 2. Pathological examinations of the giant cell tumor (A, B) revealed a characteristic background network 
of stromal mononuclear cells incorporated with many multinucleated giant cells (asterisks) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The follow-up MR images (A, B) revealed incorporation of rib grafts and instruments and satisfactory 
consolidation of fusion mass. There was no radiological evidence of tumor recurrence up to 36 months 
after surgery 
 
 
rence, now 36 months after the combined treatment 
(Figure 3). She was symptom-free, having returned 
her previous work one month after surgery. 
 
DISCUSSION 
GCT is a relatively rare, benign osteolytic skeletal 
neoplasm of young adults with predominance in fe-
males. It mostly occurs in the long bones near articu-
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 lations, and usually has a benign clinical presentation. 
GCT localized in the spine is uncommon but may 
present with a locally aggressive clinical course due to 
a complex anatomical configuration of the vertebrae [1]. 
Shankman and colleagues demonstrated that the prev-
alence of spinal localization was 2.7 % out of 1277 
reported patients with a GCT. Most spinal GCTs oc-
cur in the sacrum, followed in order of decreasing 
frequency by lumbar, cervical, and thoracic segments 
[2,3]. Actually, we have extensively reviewed the 
English literature in the past 10 years, and have found 
only twenty one reported cases that had presented with 
low back pain and were diagnosed to have a GCT in 
the thoracic vertebra [3-6]. Therefore, it is evident that 
thoracic spine GCT is a very rare event leading to 
acute paraparesis and need emergent decompressing 
surgery. 
Patients with a spinal GCT most commonly pre-
sent with persistent back pain [7]. A lumbar spine 
GCT with the involvement of the sacral plexus may 
induce bladder and bowel symptoms [8,9]. A large 
GCT tumor of the cervical/thoracic vertebrae will re-
sult in sensory and motor deficits, or even paraplegia 
of extremities secondary to spinal cord compression 
[10]. It has been proposed that female hormones, es-
pecially estrogen and progesterone, may account for 
rapid tumor growth of GCTs, because a patient with 
pregnancy has been found to have rapid recurrence of 
spinal GCT [11]. In our case, the patient suffered from 
persistent back pain for only two weeks prior to her 
acute onset of paraparesis. The exact mechanisms by 
which the tumor has a course of rapid expansion is not 
currently known, since our patient actually presented 
with normal levels of circulating estrogen and also did 
not have pregnancy or other hormone-secreting tu-
mors. Thus, the spectrum of disease behaviors in spi-
nal GCTs may be highly variable and unpredictable, 
especially in young female patients, despite the gener-
ally benign nature of the GCTs. 
Grossly, GCT is a fleshy, reddish, and homoge-
nous tumor. Focal hemorrhage or necrosis can be seen 
in many tumors. The tumor may breach the cortex and 
extend into soft tissues. Microscopically, GCTs are 
comprised of multinucleated, osteoclastic giant cells, 
which are thought to arise from mononuclear cells of 
macrophage origin [12]. The tumor exhibited promi-
nent vascularity and hemorrhage. It is generally ac-
cepted that the characteristic large osteoclastic giant 
cells are not neoplastic. The mononuclear cells, which 
represent the neoplastic component, are thought to 
arise from primitive mesenchymal stromal cells [13]. 
Histologic grading does not appear to be of value in 
predicting either locally aggressive behavior or the 
development of metastases. The stromal cells show no 
cytologic features suggestive of malignancy, unless 
associated with malignant transformation. 
Radiographically, GCT of bone usually manifests 
itself as a destructive, osteolytic lesion on plain films. 
The CT and MRI studies can provide more infor-
mation on the extent of bony involvement and the 
degree of surrounding soft tissue involvement [3]. 
The characteristic MR findings for spinal GCTs in-
clude a hypervascular mass with cystic changes with 
heterogeneous, low to intermediate signal intensity 
on T1-weighted images and low to similar signal in-
tensity relative to the normal spinal cord on T2- 
weighted images. In contrast enhanced image, GTC 
shows heterogeneous accentuating of the extent of 
paraspinal and epidural disease. Hemorrhage may 
occur and cause heterogeneous signals due to hemo-
siderin. Compression fractures may also be observed 
with tumors at the thoracolumbar spine. These MR 
findings are essential to make a differential diagnosis 
from metastastic tumors because most metastases 
show high signal intensity [8,12]. Both tumors, 
however, may need adjuvant radiation following sur-
gical excision because these tumors usually arise 
from the vertebral body but their expansive or infil-
trative parts may involve epidural space or posterior 
elements.  
Campanacci et al proposed a grading system for 
GCTs that is based on the radiographic appearance of 
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 the tumors (Table 1) [14]. It is similar to that proposed 
by Enneking for benign bone tumors (Table 2) [15], 
but lower correlation exists between the grading sys-
tems and the incidence of local recurrence or metasta-
ses. The Enneking classification combines radiologi-
cal and histological characters and corresponds more 
closely to clinical presentations. In the present case, 
the tumor extended bilaterally to the posterior spinal 
elements, pre-vertebral area and epidural space with 
cortical destruction in MRI studies. So, it can be de-
fined as a grade 3 GTC by the Campanacci Radiolog-
ical Grading System. According to the pathological 
report, there was no obvious evidence of malignant 
change. Thus, it can be defined as a stage III (aggres-
sive) GTC by the Enneking classification and pre-
sented a rapid growing and symptomatic mass as ex-
pected. 
The management of GCT is predicated on the an-
atomic site of the tumor, the extent of bone destruc-
tion, and the mitotic potential in pathological exami-
nations. It needs to be emphasized that surgery re-
mains to be the gold standard in the management of 
GCT, because an en bloc resection with wide safe 
margins provides the possibility for surgical cure [12]. 
In the management of spinal GCTs, the complex con-
figuration of vertebrae with the involvement of vital 
structures, however, precludes the attempt to obtain an 
en bloc resection with wide safe margins. In such a 
case, radiotherapy is a reasonable alternative option to 
decrease the local recurrence rate with preservation of 
spinal function, because GCT is a radiosensitive tu-
mor [8,16]. With the rapid advances in radiation ther-
apy and new techniques, disadvantages of the radio-
therapy may further be minimized, including local 
radiation effects or the potential for sarcomatous 
transformation.  
In summary, we report a rare case presenting with 
acute onset of paraparesis due to a GCT originated 
from the T7 thoracic vertebra. Through a combination 
of emergent surgical excision and adjuvant radiother-
apy, the patient made an uneventful recovery. We 
emphasize that spinal loocalization for the GCT, alt-
Table 1. Campanacci radiological grading system for giant cell tumors of bone 
Grade Description 
1 Intramedullary lesion confined to bone 
2 Thinned, expanded cortex 
3 Cortical breakout 
 
 
Table 2. Enneking classification of giant cell tumors of bone 
Stage Description Clinical presentation 
I (latent) Confined totally by bone 
Histologically benign 
Asymptomatic 
Inactive on bone scan 
II (active) Expanded cortex but no breakthrough 
Histologically benign 
Symptomatic 
Active on bone scan 
Pathological fracture 
III (aggressive) Cortical perforation with soft tissue mass 
Histologically benign 
Symptomatic 
Extensive active on bone scan 
Malignant Sarcomatous lesion May metastasis 
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 hough rare, should be included in the differential di-
agnosis for patients with pathological fractures of the 
vertebrae, especially in those non-traumatized young 
patients.  
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